Parkinson's Disease Symptoms
Parkinson's disease causes a wide range of symptoms that go far beyond the visible tremor most people associate with the condition. Symptoms are broadly divided into motor symptoms (affecting movement) and non-motor symptoms (affecting mood, cognition, sleep, and autonomic function). Non-motor symptoms are often underrecognized but can significantly impact quality of life.
Motor Symptoms
The cardinal motor features of Parkinson's disease include tremor, bradykinesia, rigidity, and postural instability. These symptoms typically begin on one side of the body and gradually progress to affect both sides.
Tremor
Tremor in Parkinson's disease is an involuntary, rhythmic, oscillatory movement of a body part, most characteristically presenting as a 4-6 Hz resting tremor of the hand described as 'pill-rolling.' It is the most recognizable motor symptom of Parkinson's disease and the presenting complaint in approximately 70% of patients at diagnosis.
Learn more →Bradykinesia
Bradykinesia is the slowness of movement and progressive reduction in the speed and amplitude of repetitive actions that defines Parkinson's disease. It is the most characteristic clinical feature required for diagnosis under both the UK Brain Bank and MDS diagnostic criteria, and represents the core motor deficit underlying the functional disability of PD.
Learn more →Muscle Rigidity
Muscle rigidity in Parkinson's disease is an increased resistance to passive movement of a limb that is present throughout the entire range of motion, independent of velocity. Unlike the velocity-dependent spasticity seen in upper motor neuron lesions, parkinsonian rigidity is constant ('lead-pipe') and may have a superimposed ratchety quality ('cogwheel') when tremor is present.
Learn more →Postural Instability
Postural instability in Parkinson's disease is the impairment of balance and postural reflexes that leads to an increased risk of falls. It typically emerges in the middle to later stages of the disease and is the motor symptom least responsive to dopaminergic medication, making it a major contributor to disability, injury, and loss of independence.
Learn more →Freezing of Gait
Freezing of gait (FOG) is a brief, episodic inability to generate effective stepping despite the intention to walk, often described as feeling that the feet are 'glued to the floor.' It is one of the most disabling and fall-provoking motor phenomena in Parkinson's disease, affecting approximately 50% of patients within 5 years of diagnosis and up to 80% in advanced disease.
Learn more →Micrographia (Small Handwriting)
Micrographia is the abnormally small, cramped handwriting that progressively shrinks across a line or page, resulting from the bradykinesia and impaired motor amplitude scaling that characterize Parkinson's disease. It is one of the earliest and most specific clinical signs of PD, often appearing before other motor symptoms are recognized, and is present in over 60% of patients at some point during the disease course.
Learn more →Dystonia
Dystonia in Parkinson's disease is the sustained or intermittent involuntary contraction of muscles causing abnormal postures or twisting movements, affecting 30-40% of patients. It can be an intrinsic disease feature or a complication of dopaminergic medication, and manifests in forms ranging from early-morning painful foot dystonia to cervical dystonia and blepharospasm.
Learn more →Non-Motor Symptoms
Non-motor symptoms can appear years before the classic motor signs and are present in nearly all patients at some point during the disease. They include changes in sleep, mood, cognition, and autonomic function.
Depression
Depression in Parkinson's disease is a clinically significant mood disorder characterized by persistent sadness, anhedonia, and neurovegetative symptoms, affecting 40-50% of patients. It is both a neurobiological consequence of PD-related neurodegeneration in serotonergic, noradrenergic, and dopaminergic pathways and a psychological response to chronic illness, making it one of the strongest determinants of reduced quality of life in PD.
Learn more →Sleep Disorders
Sleep disturbances in Parkinson's disease encompass a spectrum of disorders -- including insomnia, REM sleep behavior disorder, excessive daytime sleepiness, restless legs syndrome, and sleep apnea -- that collectively affect 60-90% of patients. Sleep dysfunction is both an early biomarker of PD neurodegeneration and a major contributor to impaired quality of life throughout the disease course.
Learn more →Cognitive Changes
Cognitive impairment in Parkinson's disease ranges from subtle executive dysfunction to frank dementia, affecting the ability to plan, concentrate, remember, and process visuospatial information. Mild cognitive impairment (MCI) affects 20-30% of newly diagnosed PD patients, while PD dementia (PDD) eventually develops in up to 80% of long-term survivors, making it one of the most consequential non-motor features of the disease.
Learn more →Constipation
Constipation in Parkinson's disease is a gastrointestinal motility disorder caused by alpha-synuclein pathology affecting the enteric nervous system, resulting in slowed colonic transit and difficulty with defecation. Affecting up to 80% of patients, constipation often appears years before motor symptoms and is one of the earliest autonomic manifestations of PD neurodegeneration.
Learn more →Speech & Voice Changes
Speech and voice changes in Parkinson's disease, collectively termed hypokinetic dysarthria, affect up to 90% of patients and include reduced vocal loudness (hypophonia), monotone speech (aprosody), imprecise articulation, and altered speech rate. These changes profoundly impact communication, social engagement, and quality of life, yet are among the most undertreated PD symptoms.
Learn more →Anxiety
Anxiety in Parkinson's disease encompasses generalized anxiety disorder, panic disorder, social phobia, and specific phobias that affect up to 40% of patients. It arises from both neurobiological changes in PD (degeneration of noradrenergic, serotonergic, and dopaminergic circuits) and psychological responses to living with a progressive, unpredictable disease, and frequently fluctuates in concert with medication cycles.
Learn more →Orthostatic Hypotension
Orthostatic hypotension (OH) in Parkinson's disease is a sustained reduction in blood pressure upon standing -- defined as a drop of 20 mmHg or more in systolic or 10 mmHg or more in diastolic blood pressure within 3 minutes of standing -- caused by autonomic nervous system degeneration. Affecting 30-50% of PD patients, OH significantly increases fall risk, reduces functional capacity, and is exacerbated by dopaminergic medications.
Learn more →Dysphagia (Swallowing Difficulty)
Dysphagia in Parkinson's disease is a disorder of swallowing function affecting the oral, pharyngeal, or esophageal phases of deglutition, caused by bradykinesia and rigidity of the swallowing musculature. Affecting up to 80% of PD patients at some point, dysphagia is a major cause of aspiration pneumonia -- the leading cause of death in Parkinson's disease.
Learn more →Drooling (Sialorrhea)
Sialorrhea (drooling) in Parkinson's disease is the involuntary loss of saliva from the mouth, affecting up to 70% of patients. Contrary to common assumption, it is caused not by excessive saliva production but by decreased frequency of spontaneous swallowing and impaired oral motor control, both consequences of PD bradykinesia affecting the oropharyngeal musculature.
Learn more →Fatigue
Fatigue in Parkinson's disease is an overwhelming sense of tiredness, lack of energy, and exhaustion that is disproportionate to physical activity level and not fully relieved by rest. It is distinct from both sleepiness and motor exhaustion, affecting up to 60% of PD patients and consistently rated among the most disabling and bothersome non-motor symptoms of the disease.
Learn more →Apathy
Apathy in Parkinson's disease is a quantitative reduction in goal-directed behavior, characterized by diminished motivation, reduced emotional responsiveness, and loss of initiative. Affecting up to 40% of patients, apathy is distinct from depression (patients may not feel sad -- they simply lack drive) and is one of the most undertreated and most caregiver-burdensome non-motor symptoms of PD.
Learn more →Hallucinations & Psychosis
Parkinson's disease psychosis encompasses a spectrum of visual perceptual disturbances ranging from benign passage hallucinations to fully formed visual hallucinations and paranoid delusions, affecting 20-40% of patients over the disease course. It results from the interplay of disease-related neurodegeneration, dopaminergic medication effects, and cognitive decline, and is one of the most powerful predictors of nursing home placement.
Learn more →Pain
Pain in Parkinson's disease is a complex, multidimensional sensory experience affecting up to 85% of patients, encompassing musculoskeletal, dystonic, central neuropathic, radicular, and akathitic subtypes. Often underrecognized and undertreated, PD pain may be the presenting symptom before motor diagnosis and fluctuates with dopaminergic medication cycles, distinguishing it from pain in the general population.
Learn more →Urinary Problems
Urinary dysfunction in Parkinson's disease encompasses overactive bladder, urgency, frequency, nocturia, and incontinence, affecting 30-70% of patients due to autonomic nervous system degeneration disrupting the neural control of bladder function. These symptoms significantly impair sleep quality, social participation, and overall quality of life.
Learn more →Sexual Dysfunction
Sexual dysfunction in Parkinson's disease encompasses a broad range of difficulties including erectile dysfunction, reduced libido, impaired arousal, difficulty achieving orgasm, and changes in sexual behavior, affecting up to 80% of men and 75% of women with PD. It is one of the most underreported and undertreated non-motor symptoms due to the stigma and discomfort surrounding sexual health discussions.
Learn more →Loss of Smell (Anosmia/Hyposmia)
Anosmia (complete loss of smell) or hyposmia (partial loss) in Parkinson's disease is an early sensory deficit caused by alpha-synuclein pathology in the olfactory bulb and anterior olfactory nucleus, affecting up to 90% of PD patients. It is one of the earliest premotor biomarkers of PD, preceding motor symptoms by 4-8 years or more, and has important implications for early detection, safety, and nutritional health.
Learn more →When to See a Doctor
If you or a loved one are experiencing tremor, slowness of movement, muscle stiffness, or changes in handwriting, walking, or facial expression, consult a neurologist. Early diagnosis allows for treatment planning that can significantly improve quality of life. While no single symptom confirms Parkinson's disease, a combination of motor and non-motor features warrants professional evaluation.